Pharmaceutical Talent Turnover Accelerates as University-Industry Collaboration Flourishes

　　【Pharmaceutical Network Industry Dynamics】 The pharmaceuticals industry is a supply-driven demand industry, where innovation can continuously create new demand for the sector, driving sustained growth. At the same time, innovation in the pharmaceuticals industry requires a constant influx of new talent, and collaboration between universities and enterprises has become an important way for many pharmaceutical companies to bring in fresh talent.
 

Recently, there have been new developments in the cooperation between pharmaceutical companies and university enterprises. Lunan Pharmaceutical announced that it has recently signed agreements with two colleges. It was reported that the renewal of the agreement to jointly build the Lunan Pharmaceutical Industry College is a summary and affirmation of past cooperation, marking a good start for further deepening such collaboration. In the future, Lunan Pharmaceutical will continue to optimize talent cultivation models and enrich corporate culture, providing strong support for strengthening university-enterprise cooperation. "The joint establishment of the Lunan Pharmaceutical Industry College achieves a close alignment between academic training and enterprise needs, enhances the quality of talent for Lunan Pharmaceutical Group Corporation, realizes the deep integration of the education chain, innovation chain, and industry chain, and lays a solid talent foundation for achieving the grand goal of 'A 100-billion-yuan Lunan, A Century-old Brand'!"
 

Recently, Hansoh Pharma also announced that, in order to strengthen school-enterprise cooperation and deepen industry-education integration, the Pharmacy Industry-Education Integration Base jointly established with Bijie Medical College – "Bijie Medical College-Hansoh Pharmaceutical Co., Ltd." – has been officially launched. Relevant representatives from Hansoh Pharmaceutical Co., Ltd. stated that this collaboration with Bijie Medical College is an attempt to further explore mechanisms and models for talent cultivation by both schools and enterprises. The focus will be on pharmaceutical R&D, production, marketing, and other industrial chain clusters, concentrating on reforming talent cultivation models through industry-education integration, school-enterprise cooperation, and work-study combination within pharmaceutical professional groups. This initiative aims to support the construction of a production-education-research-training-application teaching system, facilitate common development for both parties, and cultivate high-quality talents for society, the industry, and enterprises.
 

Recently, the Research Institute of Red Sun Pharmaceutical entered the School of Pharmacy at Tianjin Medical University for in-depth discussions on platform construction, cooperative projects, and talent cultivation between the university and the enterprise. According to reports, over the years, while growing and expanding, Red Sun Pharmaceutical has placed significant emphasis on the growth and development of traditional Chinese medicine professionals through practical work experience. The company continuously engages in deep cooperation and precise alignment with students from various universities, especially those in related fields. Red Sun Pharmaceutical and its various divisions and subsidiaries have established talent cultivation and employment practice bases with multiple institutions such as Tianjin Medical University, Changchun University of Traditional Chinese Medicine, and Jiangsu Ocean University, strengthening extensive industry-university-research collaboration.
 

In addition, the "Fudan University-Zhengzheng Pharma Complex Drug Formulation Joint Research Center," a collaboration between Fudan University and Zhengzheng (Shanghai) Biotechnology Co., Ltd., was officially inaugurated on December 9. The newly established "Fudan University-Zhengzheng Pharma Complex Drug Formulation Joint Research Center" is a technical research and development institution created through this partnership. It will focus on the research and development of complex drug formulations, relying on Fudan University while leveraging the company’s engineering design capabilities and engineering talent, as well as the pharmaceutical research expertise of the university's faculty. This collaboration establishes an integrated industry-academia-research management model. Both parties will engage in comprehensive and in-depth cooperation in areas such as "scientific research platform construction, collaborative research projects, and cultivation of high-level R&D personnel" to drive innovation and development in the pharmaceutical field.
 

The person in charge of Zenith (Shanghai) Biotechnology Co., Ltd. stated that by integrating the application research of enterprises with the basic research of universities, more innovations can be made in the field of drug delivery. The initial focus is on the direction of nano-formulations, such as the delivery of anti-tumor drugs, the delivery of small nucleic acid drugs, and the delivery of oral peptides. It also includes research on some transdermal drug delivery systems...
 

According to reports, with the innovative development of the pharmaceutical industry, nearly ten domestically produced new drugs are approved for marketing each year, and more than 200 domestic INDs are accepted. To date, over 30 biotech companies have been listed and traded on the A-share and Hong Kong stock markets. Research reports analyze that in the next five years, the number of listed innovative pharmaceutical enterprises is expected to expand to around 100. However, behind the prosperity of the industry lies the rapid turnover of talent. Therefore, strengthening talent development is an important pillar for the pharmaceutical industry's growth, and collaboration between universities and enterprises is one of the effective approaches. To better promote the development of the pharmaceutical industry, future cooperation between universities and enterprises will become increasingly frequent.